Globe Life Inc. $GL Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund lowered its holdings in Globe Life Inc. (NYSE:GL) by 93.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 5,001 shares of the company’s stock after selling 68,145 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Globe Life were worth $696,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Hilton Head Capital Partners LLC acquired a new stake in Globe Life during the fourth quarter worth approximately $30,000. CYBER HORNET ETFs LLC acquired a new position in Globe Life during the second quarter worth approximately $28,000. MUFG Securities EMEA plc purchased a new stake in Globe Life in the second quarter valued at approximately $31,000. Torren Management LLC purchased a new position in shares of Globe Life during the fourth quarter worth approximately $37,000. Finally, AdvisorNet Financial Inc increased its stake in Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. TD Cowen boosted their price target on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Jefferies Financial Group boosted their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Wells Fargo & Company increased their price target on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Finally, Piper Sandler increased their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Price Performance

Shares of NYSE:GL opened at $182.14 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The business’s fifty day moving average price is $171.52 and its two-hundred day moving average price is $154.34. The stock has a market cap of $14.14 billion, a PE ratio of 12.09 and a beta of 0.48. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm earned $3.05 earnings per share. The business’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, analysts forecast that Globe Life Inc. will post 15.7 EPS for the current fiscal year.

Insider Activity

In other news, EVP Michael Clay Majors sold 37,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at $9,560,455.52. The trade was a 40.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the sale, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 169,174 shares of company stock worth $28,553,849. Company insiders own 2.11% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.